AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2023
Dec 19, 2023
33510_dirs_2023-12-19_7111e7d3-90e5-41c2-9fb0-a9c7ae028f7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2023-12-18
Reporting Person: Williamson Robert F III (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-18 | Common Stock | P | 10000 | $0.26 | Acquired | 10000 | Direct |
| 2023-12-19 | Common Stock | P | 13680 | $0.32 | Acquired | 23680 | Direct |
More from Perspective Therapeutics, Inc.
Report Publication Announcement
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Report Publication Announcement
2026
May 11
Report Publication Announcement
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16